ストックスクリーナーアプリを入手
0.90
0.00%
0.00
アフターアワーズ：
.90
Eagle Pharmaceuticals Inc (EGRX) 最新ニュース
Eagle Pharmaceuticals to Delist from Nasdaq By Investing.com - Investing.com Australia
Eagle Pharmaceuticals, Inc. Announces Executive Changes - Marketscreener.com
Eagle Pharmaceuticals to Delist from Nasdaq - Investing.com India
Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration - The Manila Times
Eagle Pharmaceuticals to Complete Nasdaq Delisting After Trading Suspension | EGRX Stock News - StockTitan
Eagle Pharmaceuticals (NASDAQ:EGRX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Citigroup Inc's Strategic Reduction in Eagle Pharmaceuticals Inc Shares - GuruFocus.com
Creative Planning Makes New $59,000 Investment in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World
Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial OfficerWOODCLIFF LAKE, N.J. — November 12, 2024 — Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) recently announced the appointment of Christopher Krawtschuk as the Chief - Defense World
Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer - The Manila Times
Eagle Pharmaceuticals Taps Former Bluebird Bio CFO Krawtschuk to Lead Finance | EGRX Stock News - StockTitan
Nantahala Capital Management Reduces Stake in Eagle Pharmaceuticals - GuruFocus.com
Eagle Pharmaceuticals to Develop Dantrolene Sodium for Potential Treatment of Alzheimer’S Disease in Collaboration with University of Pennsylvania - Marketscreener.com
Eagle Pharmaceuticals Adopts Stockholder Rights Plan to Protect Shareholders’ Interests - Defense World
Union Square Park Capital Management, LLC Increases Stake in Eagle Pharmaceuticals Inc - GuruFocus.com
Eagle Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan - The Manila Times
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle - GlobeNewswire
Pemetrexed Market Is Booming Worldwide 2024-2031 | Stada - openPR
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceutica - GuruFocus.com
Snowflake, Eagle Pharmaceuticals, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - ForexTV.com
Snowflake, Eagle Pharmaceuticals, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - GlobeNewswire Inc.
Eagle Pharmaceuticals (NASDAQ:EGRX) Now Covered by Analysts at StockNews.com - Defense World
Global Antiemetics Drugs Market to Exhibit Growth at a CAGR of ~6% by 2030 | DelveInsight - GlobeNewswire
Union Square Park Capital Management's Strategic Acquisition of Eagle Pharmaceuticals Shares - Yahoo Finance
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.09% - MSN
Point72 Asia Singapore Pte. Ltd. Makes New $65,000 Investment in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World
AVEO Up After-Hours, Plandaí Gets Facelift, SNTA Enchants, Keep Watch On Eagle - RTTNews
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09% - MSN
Selling Buzz: Eagle Pharmaceuticals Inc [EGRX] CEO Tarriff Scott sells 10,925 shares of the company - Knox Daily
Eagle Pharmaceuticals, Inc.(OTCPK: EGRX) dropped from NASDAQ Composite Index - Marketscreener.com
Post-Trade Analysis: Eagle Pharmaceuticals Inc (EGRX) Slides -39.89, Closing at 2.14 - The Dwinnex
EGRX stock touches 52-week low at $2.78 amid market challenges By Investing.com - Investing.com South Africa
EGRX stock touches 52-week low at $2.78 amid market challenges - Investing.com
The Future of Eagle Pharmaceuticals Inc: Analyzing EGRX - The InvestChronicle
Eagle Pharmaceuticals : Non Reliance of Financial Report Form 8 K - Marketscreener.com
Rhumbline Advisers Decreases Stock Holdings in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World
Global Antiemetics And Antinauseants Market Innovations Investigated by Analysis and Share 2024 - WhaTech
173,365 Shares in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Bought by Perceptive Advisors LLC - Defense World
Towa Pharmaceutical Settles Patent Infringement Suit - TipRanks
Eagle Pharmaceuticals (NASDAQ:EGRX) Now Covered by StockNews.com - Defense World
Bendamustine Market 2024 Growth Potential, Manufacturers, Production, Revenue and Forecast 2032 Teva, Eisai, Eagle Pharmaceuticals, MundiPharma – Cauverynews - Cauverynews
Emergent Sinks on New Orders for Smallpox, Mpox Vaccine - Baystreet.ca
Emergent Biosolutions Shares Rise 16% on Orders Secured for Smallpox, Monkeypox Vaccines - MarketWatch
Fidelis Capital Partners LLC Purchases New Shares in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World
Acadian Asset Management LLC Sells 26,056 Shares of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World
First Eagle Investment Management LLC Grows Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World
Beta Blockers Global Market Report 2024: Size, Growth Rate, and Segments - WhaTech
From Rs 5.97 to Rs 47.25 per share in just 137 days: Debt-free multibagger penny stock hit back-to-back upper circuits & 52-week highs; Here’s why! - Dalal Street Investment Journal
StockNews.com Begins Coverage on Eagle Pharmaceuticals (NASDAQ:EGRX) - Defense World
Eagle Pharmaceuticals (NASDAQ:EGRX) Coverage Initiated by Analysts at StockNews.com - MarketBeat
LSV Asset Management Reduces Stake in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World
Los Angeles Capital Management LLC Cuts Stock Position in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World
StockNews.com Initiates Coverage on Eagle Pharmaceuticals (NASDAQ:EGRX) - MarketBeat
0.79%
0.15%
大文字化:
|
ボリューム (24 時間):